Connecting Black Families to Hereditary Cancer Genetic Counseling and Testing in Houston
This study aims to help Black individuals and families in Houston understand their risk for hereditary cancers like breast and colorectal cancer. We are using a simple genetic risk screening tool and offering genetic testing and counseling through community organizations. The goal is to identify individuals eligible for genetic testing, provide them with testing and counseling, and connect those with certain genetic changes to resources for reducing their cancer risk and for their family members to also get tested. We hope to identify 300 Black families and provide genetic testing to 150 Black individuals and families.
- Study design
- This is an interventional study planning to enroll 1000 participants. It focuses on connecting individuals to genetic testing and counseling.
- What's involved
- You will complete forms about your demographics and health history, and if eligible, you will complete genetic testing. The study will follow up on a questionnaire for about one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed through study completion, which is an average of one year, for the genetic risk screening tool questionnaire.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Banu Arun, MD · PRINCIPAL_INVESTIGATOR · MD Anderson Cancer Cneter
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- genetic risk screening tool (GRST) questionnairethrough study completion; an average of 1 year.